Physician

Alexander Edward Dela Cruz Drilon, MD

According to 2025 Medicare claims, Alexander Drilon, MD (NPI: 1578876876) practices medical oncology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Queens, NY. This provider's primary affiliated billing organization is MEMORIAL SOLID TUMOR GROUP (NPI: 1699746172; TIN: 133278578) and primary practice location at 10021-3402.

Drilon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 91 traditional Medicare patients, billed 226 HCPCS/CPT codes, and received $24,287 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 355 prescription claims across 53 beneficiaries totaling $2,150,694 in drug costs, led by Tagrisso (Osimertinib Mesylate). 2023 DME data shows 12 claims. Open Payments data shows 53 records totaling $1,504,985. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $67,264 to $24,287. In contrast, Part D prescription costs have risen steadily, from $899,206 to $2,150,694. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $2,521 and ending at $1,426.